Search results
Results from the WOW.Com Content Network
It should not be used in individuals with kidney or liver problems, congestive heart failure, or an allergic reaction to metformin. Some common side effects associated with Glucophage include nausea, diarrhea, and stomach upset, although these side effects are typically temporary and mild.
Find out which specific metformin products are affected by the recall. Linkedin. FDA Updates and Press Announcements on NDMA in Metformin. Show entries. Export Excel. Company. Medicine. NDC....
Why Metformin Was Recalled. What You Should Do. In May 2020, the Food and Drug Administration (FDA) released a statement regarding higher-than-acceptable levels of a substance called N-nitrosodimethylamine (NDMA) in some preparations of extended-release metformin.
Update [10/5/2020] FDA is alerting patients and health care professionals to two voluntary recalls of extended release (ER) metformin by Marksans Pharma and Sun Pharmaceutical Industries.
In 2021, one brand recalled two lots of metformin extended-release tablets from the U.S. market, as reported by the Food and Drug Administration (FDA). This is because an unacceptable level of...
Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA)...
Viona Pharmaceuticals Inc., issues voluntary nationwide recall of metformin HCl extended-release tablets, USP 750 mg, due to the detection of N-nitrosodimethylamine (NDMA) impurity.
178 lots of metformin hydrochloride, the most common type 2 diabetes drug, were recalled in 2020 by the FDA.
Viona Pharmaceuticals has voluntarily recalled 33 batches of its Metformin Hydrochloride Extended-Release 750 mg tablets sold in 100-count bottles with expiration dates ranging from June 2022 to March 2023, the Food and Drug Administration (FDA) announced on Dec. 28.
Viona Pharmaceuticals, Inc. is voluntarily recalling 23 lots of Metformin Hydrochloride Extended-Release Tablets due to the presence of the probable carcinogen NDMA. The pharmaceutical company...